Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes

L G Lyngdorf1, S Gregersen, A Daugherty

  • 1Department of Cardiology and Institute of Experimental Clinical Research, Aarhus University Hospital (Skejby Sygehus), DK-8200 Aarhus N, Denmark. linegrly@yahoo.com

Cardiovascular Research
|October 14, 2003
PubMed
Abstract

Insights

Obese, insulin-resistant mice showed less atherosclerosis than lean controls. Food restriction also reduced atherosclerosis in these atherosclerosis models, questioning mouse model relevance for obesity-related diabetes studies.

Area of Science:

  • Cardiovascular Research
  • Metabolic Syndrome Research
  • Animal Models of Disease

Background:

  • Atherosclerosis is a complex disease influenced by metabolic factors like obesity and insulin resistance.
  • Apolipoprotein E-deficient (ApoE(-/-)) mice are a common model for studying atherosclerosis.
  • The relationship between obesity-induced type 2 diabetes and atherosclerosis development requires further elucidation.

Purpose of the Study:

  • To investigate the impact of obesity and insulin resistance on atherosclerosis development in ApoE(-/-) mice.
  • To assess the effect of food restriction on atherosclerosis in ApoE(-/-) mice.
  • To evaluate the utility of ApoE(-/-) mice in modeling obesity-related diabetes and atherosclerosis.

Main Methods:

  • Sixty-eight ApoE(-/-) mice were divided into three groups: control, gold thioglucose (GTG)-injected (obesity model), and food-restricted.
  • Obesity was induced via GTG injection targeting the hypothalamic satiety center.
  • Food-restricted mice received 25% less chow than ad libitum-fed controls for 4 months.

Main Results:

  • GTG-injected mice became significantly overweight, obese, hypertriglyceridemic, insulin-resistant, hyperinsulinemic, and hyperglycemic compared to controls.
  • Unexpectedly, obese and diabetic mice exhibited significantly less atherosclerosis than lean, non-diabetic control mice.
  • Food-restricted mice also showed reduced atherosclerosis development compared to control mice.

Conclusions:

  • Obesity and diabetes in this ApoE(-/-) mouse model were paradoxically associated with reduced atherosclerosis.
  • These findings raise questions about the validity of using ApoE(-/-) mice to study the link between obesity-related type 2 diabetes and atherosclerosis.
  • The relevance of results from ApoE(-/-) mice with attenuated weight gain in intervention studies may be limited.

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.